FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2169275199> ?p ?o ?g. }

• W2169275199 endingPage "464" @default.
• W2169275199 startingPage "457" @default.
• W2169275199 abstract "Results of a combined modality adjuvant pilot program of low-dose continuous-infusion 5-fluorouracil, whole-abdominal radiation, and tumor bed boost in patients with colon cancer with involved nodes and serosal involvement are presented.Forty-one eligible patients with completely resected T3N1-2M0 colon cancer (modified Astler-Coller C2) were treated with 5-fluorouracil (5-FU) at a dose of 200 mg/m2/day by continuous infusion and 30 Gy of concomitant whole-abdominal radiation in 1 Gy fractions. An additional 16 Gy boost to the tumor bed was administered in 1.6 Gy fractions. After completion of combined modality treatment and a 21-day rest period, patients received 4 days of 5-FU at a dose of 1000 mg/m2 by continuous infusion every 28 days for nine cycles.Five-year disease-free and overall survival estimates were 58 and 67%, respectively, for all T3N1-2 patients. Five-year disease-free and overall survival estimates for the 19 patients with four or fewer nodes were both 61%. Five-year disease-free survival and overall survival estimates for the 20 patients with more than four involved nodes were 55% and 74%, respectively (the exact number of involved nodes were unknown for two patients). Disease-free and overall survival estimates for patients treated with 5-FU and radiation compare favorably to the 5-FU plus levamisole arm of the intergroup adjuvant colon study (Int 0035/SWOG 8591) in patients with more than four positive nodes where the 5-year disease-free and overall survival estimates were 35% and 39%, respectively. Disease-free and overall survival estimates for patients with four or fewer nodes in the 5-FU plus levamisole arm of the intergroup study were 64 and 68%, which is not markedly different from results obtained with radiation and 5-FU in the current study. There were no treatment-related fatalities. Seventeen percent of patients had severe and 7% had life-threatening toxicity of any kind. One patient had an acute partial bowel obstruction and two patients had chronic low grade enteritis.Continuous infusion 5-FU and whole-abdominal radiation with tumor bed boost should be further investigated in a larger trial of T3N1-2 colon cancer." @default.
• W2169275199 created "2016-06-24" @default.
• W2169275199 creator A5003970395 @default.
• W2169275199 creator A5004963523 @default.
• W2169275199 creator A5026563364 @default.
• W2169275199 creator A5038888315 @default.
• W2169275199 creator A5050307933 @default.
• W2169275199 creator A5051434093 @default.
• W2169275199 creator A5059485304 @default.
• W2169275199 creator A5069947864 @default.
• W2169275199 creator A5077337021 @default.
• W2169275199 creator A5089221698 @default.
• W2169275199 date "1995-05-01" @default.
• W2169275199 modified "2023-09-27" @default.
• W2169275199 title "Adjuvant continuous infusion 5-FU, whole-abdominal radiation, and tumor bed boost in high-risk stage III colon carcinoma: A southwest oncology group pilot study" @default.
• W2169275199 cites W1908061147 @default.
• W2169275199 cites W2001044764 @default.
• W2169275199 cites W2013398567 @default.
• W2169275199 cites W2014047884 @default.
• W2169275199 cites W2024838895 @default.
• W2169275199 cites W2087835174 @default.
• W2169275199 cites W2104702541 @default.
• W2169275199 cites W2148228538 @default.
• W2169275199 cites W2154674991 @default.
• W2169275199 cites W2170457241 @default.
• W2169275199 cites W2313857605 @default.
• W2169275199 cites W4243367196 @default.
• W2169275199 cites W4255986575 @default.
• W2169275199 cites W4293241248 @default.
• W2169275199 doi "https://doi.org/10.1016/0360-3016(94)00600-p" @default.
• W2169275199 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7751186" @default.
• W2169275199 hasPublicationYear "1995" @default.
• W2169275199 type Work @default.
• W2169275199 sameAs 2169275199 @default.
• W2169275199 citedByCount "29" @default.
• W2169275199 countsByYear W21692751992015 @default.
• W2169275199 countsByYear W21692751992017 @default.
• W2169275199 countsByYear W21692751992018 @default.
• W2169275199 countsByYear W21692751992020 @default.
• W2169275199 countsByYear W21692751992021 @default.
• W2169275199 countsByYear W21692751992022 @default.
• W2169275199 crossrefType "journal-article" @default.
• W2169275199 hasAuthorship W2169275199A5003970395 @default.
• W2169275199 hasAuthorship W2169275199A5004963523 @default.
• W2169275199 hasAuthorship W2169275199A5026563364 @default.
• W2169275199 hasAuthorship W2169275199A5038888315 @default.
• W2169275199 hasAuthorship W2169275199A5050307933 @default.
• W2169275199 hasAuthorship W2169275199A5051434093 @default.
• W2169275199 hasAuthorship W2169275199A5059485304 @default.
• W2169275199 hasAuthorship W2169275199A5069947864 @default.
• W2169275199 hasAuthorship W2169275199A5077337021 @default.
• W2169275199 hasAuthorship W2169275199A5089221698 @default.
• W2169275199 hasConcept C121608353 @default.
• W2169275199 hasConcept C126322002 @default.
• W2169275199 hasConcept C126894567 @default.
• W2169275199 hasConcept C141071460 @default.
• W2169275199 hasConcept C143998085 @default.
• W2169275199 hasConcept C146357865 @default.
• W2169275199 hasConcept C151730666 @default.
• W2169275199 hasConcept C2777546739 @default.
• W2169275199 hasConcept C2777863537 @default.
• W2169275199 hasConcept C2779384505 @default.
• W2169275199 hasConcept C2780456651 @default.
• W2169275199 hasConcept C2991914351 @default.
• W2169275199 hasConcept C509974204 @default.
• W2169275199 hasConcept C526805850 @default.
• W2169275199 hasConcept C71924100 @default.
• W2169275199 hasConcept C86803240 @default.
• W2169275199 hasConcept C90924648 @default.
• W2169275199 hasConceptScore W2169275199C121608353 @default.
• W2169275199 hasConceptScore W2169275199C126322002 @default.
• W2169275199 hasConceptScore W2169275199C126894567 @default.
• W2169275199 hasConceptScore W2169275199C141071460 @default.
• W2169275199 hasConceptScore W2169275199C143998085 @default.
• W2169275199 hasConceptScore W2169275199C146357865 @default.
• W2169275199 hasConceptScore W2169275199C151730666 @default.
• W2169275199 hasConceptScore W2169275199C2777546739 @default.
• W2169275199 hasConceptScore W2169275199C2777863537 @default.
• W2169275199 hasConceptScore W2169275199C2779384505 @default.
• W2169275199 hasConceptScore W2169275199C2780456651 @default.
• W2169275199 hasConceptScore W2169275199C2991914351 @default.
• W2169275199 hasConceptScore W2169275199C509974204 @default.
• W2169275199 hasConceptScore W2169275199C526805850 @default.
• W2169275199 hasConceptScore W2169275199C71924100 @default.
• W2169275199 hasConceptScore W2169275199C86803240 @default.
• W2169275199 hasConceptScore W2169275199C90924648 @default.
• W2169275199 hasIssue "2" @default.
• W2169275199 hasLocation W21692751991 @default.
• W2169275199 hasLocation W21692751992 @default.
• W2169275199 hasOpenAccess W2169275199 @default.
• W2169275199 hasPrimaryLocation W21692751991 @default.
• W2169275199 hasRelatedWork W1970193197 @default.
• W2169275199 hasRelatedWork W2055802692 @default.
• W2169275199 hasRelatedWork W2155941014 @default.
• W2169275199 hasRelatedWork W2336726368 @default.
• W2169275199 hasRelatedWork W2398825736 @default.
• W2169275199 hasRelatedWork W2402640364 @default.
• W2169275199 hasRelatedWork W2427058397 @default.

• next